S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.47 (+0.33%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.47 (+0.33%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.47 (+0.33%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.47 (+0.33%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
NYSE:TBI

TrueBlue (TBI) Stock Forecast, Price & News

$14.82
+0.15 (+1.02%)
(As of 02:19 PM ET)
Compare
Today's Range
$14.49
$14.89
50-Day Range
$13.70
$18.29
52-Week Range
$13.52
$22.31
Volume
110,749 shs
Average Volume
211,777 shs
Market Capitalization
$459.42 million
P/E Ratio
31.53
Dividend Yield
N/A
Price Target
$19.00

TrueBlue MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
29.4% Upside
$19.00 Price Target
Short Interest
Healthy
1.86% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
260.42%
From $0.48 to $1.73 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.77 out of 5 stars

Business Services Sector

33rd out of 317 stocks

Help Supply Services Industry

6th out of 18 stocks


TBI stock logo

About TrueBlue (NYSE:TBI) Stock

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company's PeopleReady segment provides general, industrial, and skilled trade staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. Its PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehouse, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company's PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform which uses artificial intelligence and machine learning for real-time insights; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company is headquartered in Tacoma, Washington.

TBI Price History

TBI Stock News Headlines

PeopleReady Announces Two Senior Leadership Appointments
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
TrueBlue Promotes Taryn Owen To President & CEO
TrueBlue, Inc. Common Stock (TBI)
Positive Report for Trueblue (TBI) from BMO Capital
Why TrueBlue Shares Are Diving Today
Q2 2023 TrueBlue Inc Earnings Call
TrueBlue Reports Second Quarter 2023 Results
TrueBlue's Earnings Outlook
PeopleReady Hits Home Run in Summer Events Staffing
Reasons to Invest in TrueBlue (TBI)
See More Headlines
Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

TBI Company Calendar

Last Earnings
7/24/2023
Today
10/02/2023
Next Earnings (Estimated)
10/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
6,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.00
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
+29.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$62.27 million
Pretax Margin
1.01%

Debt

Sales & Book Value

Annual Sales
$2.25 billion
Cash Flow
$3.38 per share
Book Value
$15.17 per share

Miscellaneous

Free Float
29,765,000
Market Cap
$454.77 million
Optionable
Optionable
Beta
1.38
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Ms. Taryn R. OwenMs. Taryn R. Owen (Age 44)
    CEO, Pres & Director
    Comp: $1.49M
  • Mr. Derrek L. GaffordMr. Derrek L. Gafford (Age 52)
    Exec. VP & CFO
    Comp: $1.08M
  • Mr. Garrett R. Ferencz (Age 45)
    Exec. VP, Gen. Counsel, Chief Ethics & Compliance Officer, Chief Legal Officer and Sec.
    Comp: $829.56k
  • Mr. Steven C. Cooper (Age 60)
    Advisor
    Comp: $2.08M
  • Mr. Carl R. Schweihs (Age 38)
    Exec. VP & Pres of People Management
    Comp: $1.1M
  • Mr. Richard B. Christensen (Age 46)
    Sr. VP, Chief Accounting Officer & Treasurer
  • Mr. Jeff Dirks
    Sr. VP, Chief Information & Technology Officer
  • Ms. Caroline Sabetti
    Chief Marketing & Communications Officer
  • Mr. Anthony Brew
    Chief Diversity Officer
  • Mr. Richard P. Betori
    Pres of PeopleScout













TBI Stock - Frequently Asked Questions

Should I buy or sell TrueBlue stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TBI shares.
View TBI analyst ratings
or view top-rated stocks.

What is TrueBlue's stock price forecast for 2023?

1 analysts have issued 1-year target prices for TrueBlue's stock. Their TBI share price forecasts range from $18.00 to $20.00. On average, they predict the company's share price to reach $19.00 in the next year. This suggests a possible upside of 29.5% from the stock's current price.
View analysts price targets for TBI
or view top-rated stocks among Wall Street analysts.

How have TBI shares performed in 2023?

TrueBlue's stock was trading at $19.58 at the start of the year. Since then, TBI stock has decreased by 25.1% and is now trading at $14.67.
View the best growth stocks for 2023 here
.

When is TrueBlue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 23rd 2023.
View our TBI earnings forecast
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) announced its earnings results on Monday, July, 24th. The business services provider reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.06. The business services provider had revenue of $475.59 million for the quarter, compared to analyst estimates of $496.11 million. TrueBlue had a net margin of 0.78% and a trailing twelve-month return on equity of 8.88%. The company's revenue for the quarter was down 16.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.82 EPS.

What ETF holds TrueBlue's stock ?

First Trust Dow Jones Select Microcap Index Fund holds 83,212 shares of TBI stock, representing 0.79% of its portfolio.

What guidance has TrueBlue issued on next quarter's earnings?

TrueBlue updated its third quarter 2023 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $483.61 million-$506.63 million, compared to the consensus revenue estimate of $516.88 million.

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

What is TrueBlue's stock symbol?

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

How do I buy shares of TrueBlue?

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TrueBlue's stock price today?

One share of TBI stock can currently be purchased for approximately $14.67.

How much money does TrueBlue make?

TrueBlue (NYSE:TBI) has a market capitalization of $454.77 million and generates $2.25 billion in revenue each year. The business services provider earns $62.27 million in net income (profit) each year or $0.47 on an earnings per share basis.

How many employees does TrueBlue have?

The company employs 6,500 workers across the globe.

How can I contact TrueBlue?

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The official website for the company is www.trueblue.com. The business services provider can be reached via phone at (253) 383-9101, via email at investorrelations@trueblueinc.com, or via fax at 877-733-0399.

This page (NYSE:TBI) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -